SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-18-017233
Filing Date
2018-01-23
Accepted
2018-01-23 14:46:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d526690dsc14d9.htm SC 14D9 8503
2 EX-99.A d526690dex99a.htm EX-99.A 13300
3 EX-99.B d526690dex99b.htm EX-99.B 13172
  Complete submission text file 0001193125-18-017233.txt   36565
Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filed by) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-88476 | Film No.: 18542105
SIC: 2836 Biological Products, (No Diagnostic Substances)